New River names new VP of sales

Share this article:
New River Pharmaceuticals named James Shaffer as VP of sales and marketing to oversee the anticipated launch of the company's attention deficit-hyperactivity disorder (ADHD) drug Vyvanse.
Shaffer joins New River from Prestwick Pharmaceuticals. Shaffer served as senior director, commercial operations at Prestwick since 2004. Prior to that, he worked at Intermune as national sales director.

New River will co-market Vyvanse along with Shire. Vyvanse is expected to follow in the footsteps of Shire's ADHD market-leading Adderall XR but is formulated to be harder to abuse.

Share this article:
close

Next Article in News

Email Newsletters

More in News

BMS Q2 sales slip, Eliquis, Yervoy soar

BMS Q2 sales slip, Eliquis, Yervoy soar

The company attributed part of the Eliquis boost to the BMS-Pfizer DTC and education efforts.

Gilead, Merck HCV marketing battle may be on horizon

Gilead, Merck HCV marketing battle may be on ...

Disclosed in its earnings report yesterday, Gilead may have a card up its sleeve to counter Merck's experimental hep. C combo regimen.

Sales of Biogen MS pill pick up overseas

Sales of Biogen MS pill pick up overseas

Biogen Idec is seeing strong sales for blockbuster MS drug Tecfidera, especially overseas where it's beginning to catch fire this summer.